Business & Finance Chinese biopharma stocks jump as U.S. weighs keeping door open to drug deals
Chinese biopharma stocks rose on Monday after a report that the U.S. may continue to allow most drug licensing deals with Chinese firms.
By
· September 21, 2026 · 1 min read
This article was originally published by
CNBC Top News
and is republished here under license.
Chinese biopharma stocks rose on Monday after a report that the U.S. may continue to allow most drug licensing deals with Chinese firms.
Related
South Korea’s central bank began testing a system for round-the-clock won payments, laying the groundwork for greater foreign access to…
By
· September 21, 2026 · 1 min read
Oil fell Monday, as traders keep watch for a recovery in shipments from Saudi Arabia, even as Mideast tensions continue…
By
· September 21, 2026 · 1 min read
Wall Street is coming off a mixed week for the major averages.…
By
· September 21, 2026 · 1 min read
Leave a Reply